Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 2 |
2007 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.
Oncol Res. 2020 Dec 10;28(5):451-465. doi: 10.3727/096504020X15898794315356. Epub 2020 May 15.
Oncol Res. 2020.
PMID: 32430093
Free PMC article.
N-benzyladriamycin-14-valerate (AD 198) activates protein kinase C-delta holoenzyme to trigger mitochondrial depolarization and cytochrome c release independently of permeability transition pore opening and Ca2+ influx.
Lothstein L, Savranskaya L, Barrett CM, Israel M, Sweatman TW.
Lothstein L, et al.
Anticancer Drugs. 2006 Jun;17(5):495-502. doi: 10.1097/00001813-200606000-00002.
Anticancer Drugs. 2006.
PMID: 16702805
Item in Clipboard
N-Benzyladriamycin-14-valerate (AD 198): a non-cardiotoxic anthracycline that is cardioprotective through PKC-epsilon activation.
Hofmann PA, Israel M, Koseki Y, Laskin J, Gray J, Janik A, Sweatman TW, Lothstein L.
Hofmann PA, et al.
J Pharmacol Exp Ther. 2007 Nov;323(2):658-64. doi: 10.1124/jpet.107.126110. Epub 2007 Aug 10.
J Pharmacol Exp Ther. 2007.
PMID: 17693586
Item in Clipboard
N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity.
Lothstein L, Savranskaya L, Sweatman TW.
Lothstein L, et al.
Leuk Res. 2007 Aug;31(8):1085-95. doi: 10.1016/j.leukres.2006.11.003. Epub 2006 Dec 21.
Leuk Res. 2007.
PMID: 17187856
Item in Clipboard
Cite
Cite